348 related articles for article (PubMed ID: 26332878)
1. Clinical Performance of the New Gore Septal Occluder in Patent Foramen Ovale Closure: A Single-Center Experience.
Sganzerla P; Rondi M; Pavone A; Aiolfi E; Facchinetti A; Funaro A; Negrini P
J Invasive Cardiol; 2015 Sep; 27(9):430-4. PubMed ID: 26332878
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter PFO closure with GORE(®) septal occluder: early and mid-term clinical results.
Butera G; Saracino A; Danna P; Sganzerla P; Chessa M; Carminati M
Catheter Cardiovasc Interv; 2013 Nov; 82(6):944-9. PubMed ID: 23897659
[TBL] [Abstract][Full Text] [Related]
3. Initial use of the new GORE(®) septal occluder in patent foramen ovale closure: implantation and preliminary results.
MacDonald ST; Daniels MJ; Ormerod OJ
Catheter Cardiovasc Interv; 2013 Mar; 81(4):660-5. PubMed ID: 23436483
[TBL] [Abstract][Full Text] [Related]
4. A Comparison Between Gore Cardioform and Amplatzer Septal Occluder for Percutaneous Closure of Patent Foramen Ovale Associated With Atrial Septal Aneurysm: Clinical and Echocardiographic Outcomes.
Musto C; Cifarelli A; Dipasquale F; Chin D; Nazzaro MS; Stio RE; Pennacchi M; De Felice F
J Invasive Cardiol; 2021 Nov; 33(11):E857-E862. PubMed ID: 34653958
[TBL] [Abstract][Full Text] [Related]
5. Using the GORE® Septal Occluder (GSO) in challenging patent foramen ovale (PFO) anatomies.
Geis NA; Pleger ST; Katus HA; Hardt SE
J Interv Cardiol; 2015 Apr; 28(2):190-7. PubMed ID: 25728716
[TBL] [Abstract][Full Text] [Related]
6. Initial clinical experience with the GORE septal occluder for the treatment of atrial septal defects and patent foramen ovale.
Freixa X; Ibrahim R; Chan J; Garceau P; Dore A; Marcotte F; Mercier LA; Mongeon FP; Basmadjian A; Khairy P; Asgar AW
EuroIntervention; 2013 Sep; 9(5):629-35. PubMed ID: 24058079
[TBL] [Abstract][Full Text] [Related]
7. Results of percutaneous closure of patent foramen ovale with the GORE(®) septal occluder.
Knerr M; Bertog S; Vaskelyte L; Hofmann I; Sievert H
Catheter Cardiovasc Interv; 2014 Jun; 83(7):1144-51. PubMed ID: 24323667
[TBL] [Abstract][Full Text] [Related]
8. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
Aral M; Mullen M
Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
[TBL] [Abstract][Full Text] [Related]
9. Transcranial doppler quantification of residual shunt after percutaneous patent foramen ovale closure: efficacy of the GORE(®) HELEX septal occluder.
Sorensen SG; Smout R; Spruance SL
J Interv Cardiol; 2011 Aug; 24(4):366-72. PubMed ID: 21492220
[TBL] [Abstract][Full Text] [Related]
10. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
[TBL] [Abstract][Full Text] [Related]
11. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
Marchese N; Pacilli MA; Inchingolo V; Fanelli R; Loperfido F; Vigna C
EuroIntervention; 2013 Jul; 9(3):382-8. PubMed ID: 23872652
[TBL] [Abstract][Full Text] [Related]
12. Transcranial Doppler quantification of residual shunt after percutaneous patent foramen ovale closure. Comparison of two devices.
Sorensen SG; Aguilar H; McKnight WK; Thomas H; Muhlestein JB
J Interv Cardiol; 2010 Dec; 23(6):575-80. PubMed ID: 20796165
[TBL] [Abstract][Full Text] [Related]
13. Management of residual shunts after initial percutaneous patent foramen ovale closure: a single center experience with immediate and long-term follow-up.
Diaz T; Cubeddu RJ; Rengifo-Moreno PA; Cruz-Gonzalez I; Solis-Martin J; Buonanno FS; Inglessis I; Palacios IF
Catheter Cardiovasc Interv; 2010 Jul; 76(1):145-50. PubMed ID: 20578100
[TBL] [Abstract][Full Text] [Related]
14. Patent foramen ovale closure with the Gore septal occluder: initial UK experience.
Thomson JD; Hildick-Smith D; Clift P; Morgan G; Daniels M; Henderson R; Spence MS; Mahadevan VS; Crossland D; Ormerod O
Catheter Cardiovasc Interv; 2014 Feb; 83(3):467-73. PubMed ID: 23766247
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter interatrial septal defect closure in a large cohort: midterm follow-up results.
Aytemir K; Oto A; Özkutlu S; Canpolat U; Kaya EB; Yorgun H; Şahiner L; Sunman H; Ateş AH; Kabakçı G
Congenit Heart Dis; 2013; 8(5):418-27. PubMed ID: 23601507
[TBL] [Abstract][Full Text] [Related]
16. Comparison of residual shunt rates in five devices used to treat patent foramen ovale.
Matsumura K; Gevorgyan R; Mangels D; Masoomi R; Mojadidi MK; Tobis J
Catheter Cardiovasc Interv; 2014 Sep; 84(3):455-63. PubMed ID: 24550064
[TBL] [Abstract][Full Text] [Related]
17. Risk of cerebral embolism after interventional closure of symptomatic patent foramen ovale or atrial septal defect: a diffusion-weighted MRI and neuron-specific enolase-based study.
Oktay Tureli H; Ungan I; Tureli D; Demir B; Pirhan O; Bayrak HI; Caglar IM; Karakaya O; Inci E
J Invasive Cardiol; 2013 Oct; 25(10):519-24. PubMed ID: 24088426
[TBL] [Abstract][Full Text] [Related]
18. Residual Shunt after Patent Foramen Ovale Device Closure in Patients With Cryptogenic Stroke: Serial Bubble Contrast Transesophageal Echocardiography Data.
Moon J; Kim M; Oh PC; Shin DH; Park HM; Jo YY; Lee JS; Kang WC
J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):347-353. PubMed ID: 30396838
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter patent foramen ovale closure is effective in reducing migraine independently from specific interatrial septum anatomy and closure devices design.
Rigatelli G; Cardaioli P; Dell'Avvocata F; Giordan M; Braggion G; Chinaglia M; Roncon L
Cardiovasc Revasc Med; 2010; 11(1):29-33. PubMed ID: 20129358
[TBL] [Abstract][Full Text] [Related]
20. Figulla PFO occluder versus Amplatzer PFO occluder for percutaneous closure of patent foramen ovale.
Saguner AM; Wahl A; Praz F; de Marchi SF; Mattle HP; Cook S; Windecker S; Meier B
Catheter Cardiovasc Interv; 2011 Apr; 77(5):709-14. PubMed ID: 20931665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
